Verve Ventures invests in early-stage European deep tech startups at the intersection of science and enterprise, focusing on the convergence of biology, engineering, and data to unlock precise, efficient, and accessible healthcare solutions.
About Verve Ventures
Verve Ventures is a Swiss-based venture investment platform at verve.vc, historically known for connecting private investors and family offices with curated early-stage and growth-stage technology deals across Europe. While the input record lacks LinkedIn, Crunchbase, and explicit stage or sector data, Verve is publicly understood as a syndicated investor model with breadth across deep tech, fintech, climate, and selective healthtech opportunities, primarily operating in the Swiss and broader European ecosystem. For healthcare AI founders, Verve is a relevant target if you are running a Series A or B priced round in Europe, have meaningful traction, and value access to a network of Swiss and European private investors who can co-invest alongside institutional leads. Pre-seed and very early seed founders are typically too early for the platform’s process, and US-only companies without European market presence are not the right geographic fit. Healthcare AI verticals that align include diagnostics, digital therapeutics, medical imaging software, and clinical workflow tools with European hospital or payer traction. Check sizes deployed through the platform typically span EUR 1M to EUR 10M aggregated across the syndicate, with capacity to scale higher in larger rounds. Best entry path is a warm introduction through a Swiss or German venture ecosystem connector, a current Verve portfolio founder, or a Zurich-based banker active in healthtech. The platform’s model means founders should expect a structured diligence process and a syndicate-style closing rather than a single-partner term sheet; plan timeline and dataroom accordingly.
Founder reviews
Other portfolio companies
Companies in Verve Ventures's portfolio not currently in our directory.
- Ikerian · 2019
- Orakl Oncology · 2023
- Limula · 2024
- Memo Therapeutics · 2023
- ONWARD · 2021
- MultiOmic
- Aktiia
- Biograil
Team
Pitch / review this investor
Have you raised from Verve Ventures? Founders only — share your honest experience (anonymous OK, moderated before publishing).